For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
According to our LPI (LP Information) latest study, the global Rosuvastatin Calcium market size was valued at US$ 514.3 million in 2023. With growing demand in downstream market, the Rosuvastatin Calcium is forecast to a readjusted size of US$ 683.6 million by 2030 with a CAGR of 4.1% during review period.
The research report highlights the growth potential of the global Rosuvastatin Calcium market. Rosuvastatin Calcium are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Rosuvastatin Calcium. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Rosuvastatin Calcium market.
Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).
Rosuvastatin Calcium is a member of the drug class of statins, used in combination with exercise, diet, and weight-loss to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body. Rosuvastatin Calcium was developed by Shionogi and has been formulated into finished oral dosage form and marketedby AstraZeneca as Crestor, Abbott Laboratories as R2.
In additional, EU is also the largest consumer of rosuvastatin calcium, about 34% of the global production was consumed in EU. China is the second producer with the market share of 28%. Top Three manufacturers in rosuvastatin calcium are AstraZeneca, MSN Laboratories, Changzhou Pharmaceutical Factory, according for 55% of the total amount.
Key Features:
The report on Rosuvastatin Calcium market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Rosuvastatin Calcium market. It may include historical data, market Segmentation by Type (e.g., Purity 98.0%, Purity 99.0%), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Rosuvastatin Calcium market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Rosuvastatin Calcium market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Rosuvastatin Calcium industry. This include advancements in Rosuvastatin Calcium technology, Rosuvastatin Calcium new entrants, Rosuvastatin Calcium new investment, and other innovations that are shaping the future of Rosuvastatin Calcium.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Rosuvastatin Calcium market. It includes factors influencing customer ' purchasing decisions, preferences for Rosuvastatin Calcium product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Rosuvastatin Calcium market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Rosuvastatin Calcium market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Rosuvastatin Calcium market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Rosuvastatin Calcium industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Rosuvastatin Calcium market.
Market Segmentation:
Rosuvastatin Calcium market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Purity 98.0%
- Purity 99.0%
- Other
Segmentation by application
- Tablet (including dispersible tablet and general tablet)
- Capsule
- Others
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- AstraZeneca
- Teva Pharmaceutical Industries
- MSN Laboratories
- Cadila Pharmaceuticals
- LGM Pharma
- Bal Pharma
- Changzhou Pharmaceutical Factory
- Jingxin Pharm
- Zhejiang Hisun Pharmaceutical
- HEC Pharm
- Lunan Pharmaceutical
- Nanjing Frochem Tech
- Lianyungang Runzhong Pharmaceutical
- Shandong Bechem Chemicals
- CTX Life Sciences
Key Questions Addressed in this Report
What is the 10-year outlook for the global Rosuvastatin Calcium market?
What factors are driving Rosuvastatin Calcium market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rosuvastatin Calcium market opportunities vary by end market size?
How does Rosuvastatin Calcium break out type, application?